loading page

Culture Result Discrepancy Between Laboratories for Nontuberculous Mycobacteria in Patients with Cystic Fibrosis
  • +1
  • Mariana Bedoya,
  • Max Salfinger,
  • Alejandra Weisman,
  • Andrew Colin
Mariana Bedoya
Monroe Carell Junior Children's Hospital at Vanderbilt

Corresponding Author:[email protected]

Author Profile
Max Salfinger
University of South Florida Morsani College of Medicine
Author Profile
Alejandra Weisman
University of Miami School of Medicine
Author Profile
Andrew Colin
University of Miami School of Medicine
Author Profile


NTM-infected CF patients may be at risk of being underdiagnosed or inappropriately treated when relying on culture and susceptibility results from non-specialized laboratories. Since this was a small study with convenience samples, a larger study needs to be carried out. If our findings are confirmed, the drivers should be elucidated for the discrepant results. Given the increasing prevalence of NTM in the population at large and not in the CF community alone[[13]](#ref-0013), elucidating any differences in testing to ensure the correct identification, including subspeciation and antimicrobial susceptibilities should be paramount
17 Aug 2022Submitted to Pediatric Pulmonology
17 Aug 2022Submission Checks Completed
17 Aug 2022Assigned to Editor
23 Aug 2022Reviewer(s) Assigned
08 Sep 2022Review(s) Completed, Editorial Evaluation Pending
15 Sep 2022Editorial Decision: Revise Major
08 Dec 20221st Revision Received
08 Dec 2022Submission Checks Completed
08 Dec 2022Review(s) Completed, Editorial Evaluation Pending
08 Dec 2022Assigned to Editor
08 Dec 2022Reviewer(s) Assigned
19 Dec 2022Editorial Decision: Revise Minor
25 Jan 20232nd Revision Received
25 Jan 2023Assigned to Editor
25 Jan 2023Review(s) Completed, Editorial Evaluation Pending
25 Jan 2023Reviewer(s) Assigned
25 Jan 2023Submission Checks Completed
06 Feb 2023Editorial Decision: Accept